Parliament w/c 06 Mar 2019

05.03.2019 – HoC – Public Bill Committee
Children Act 1989 (Amendment) (Female Genital Mutilation) Bill [Lords]

05.03.2019 – HoL – Oral questions
Ensuring there are sufficient specialist staff to achieve the priority ambition for stroke care – Baroness Wheeler

06.03.2019 – HoC – Fifteenth Delegated Legislation Committee
Draft Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 and the draft Medical Devices (Amendment etc.) (EU Exit) Regulations 2019

07.03.2019 – HoC – Health and Social Care – Oral Evidence Session
Availability of Orkambi on the NHS
A patient representative nominated by the Cystic Fibrosis Trust
A clinician representative nominated by the Cystic Fibrosis Trust
Professor Stephen Powis, National Medical Director, NHS England
John Stewart, National Director, Specialised Commissioning, NHS England
Sir Andrew Dillon, Chief Executive, NICE
Meindert Boysen, Director of the Centre for Health Technology Evaluation, NICE
Dr Jeff Leiden, Chairman, President and Chief Executive Officer, Vertex Pharmaceuticals
Stuart A. Arbuckle, Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals

07.03.2019 – HoL – Oral questions
Reducing the risk of female genital mutilation for girls in the UK and internationally – Baroness Jenkin of Kennington

07.03.2019 – HoL – Oral questions
Bringing section 106 of the Equality Act 2010 into force – Baroness Gale

07.03.2019 – HoL – Orders and regulations
European Qualifications (Health and Social Care Professions) (Amendment etc.) (EU Exit) Regulations 2018 – Motion to approve – Baroness Blackwood of North Oxford

07.03.2019 – HoL – Orders and regulations
European Qualifications (Health and Social Care Professions) (Amendment etc.) (EU Exit) Regulations 2018 – Motion to regret – Baroness Thornton

07.03.2019 – HoL – Orders and regulations
Draft European Qualifications (Pharmacists) (Amendment etc.) (EU Exit) Regulations (Northern Ireland) 2018 – Baroness Blackwood of North Oxford

07.03.2019 – HoL – Orders and regulations
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019; Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019; Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 – Baroness Blackwood of North Oxford

%d bloggers like this: